Nationwide Fund Advisors - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 85 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q1 2016$30,000
-63.9%
28,2620.0%0.00%
Q4 2015$83,000
-6.7%
28,2620.0%0.00%
Q3 2015$89,000
-93.5%
28,262
-87.8%
0.00%
-100.0%
Q2 2015$1,372,000
-6.6%
231,762
+68.6%
0.01%0.0%
Q1 2015$1,469,000
+469.4%
137,433
+399.6%
0.01%
+500.0%
Q4 2014$258,000
+20.0%
27,509
-1.9%
0.00%0.0%
Q3 2014$215,000
-13.7%
28,053
+1.0%
0.00%0.0%
Q2 2014$249,000
+232.0%
27,772
+98.7%
0.00%
Q1 2014$75,000
+114.3%
13,9770.0%0.00%
Q4 2013$35,000
-7.9%
13,9770.0%0.00%
Q3 2013$38,000
+11.8%
13,977
+46.8%
0.00%
Q2 2013$34,0009,5190.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2014
NameSharesValueWeighting ↓
Aisling Capital LLC 2,010,000$905,0000.21%
GLOBEFLEX CAPITAL L P 226,959$102,0000.03%
ACUTA CAPITAL PARTNERS, LLC 62,800$28,0000.01%
MENTA CAPITAL LLC 195,136$87,0000.01%
Orbimed Advisors 1,073,000$481,0000.01%
GOODWIN DANIEL L 22,679$10,0000.00%
TUDOR INVESTMENT CORP ET AL 215,800$97,0000.00%
Renaissance Technologies 2,214,396$992,0000.00%
STOCK YARDS BANK & TRUST CO 30,170$14,0000.00%
HIGHLAND CAPITAL MANAGEMENT, LLC 41,000$18,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders